Every Day Counts in the Race Against Cancer
Agilent is dedicated to pushing the boundaries of cancer research and diagnostics.
Our innovative solutions and strategic partnerships are at the forefront of transforming cancer care, enabling us to deliver comprehensive multiomic insights and cutting-edge diagnostic tools that empower researchers and clinicians to make more informed decisions and ultimately improve patient care. Whether your early discovery research, clinical trials or diagnostic tools development, Agilent is there to support scientists with an integrated portfolio of solutions.
New Product Introductions
Coming soon...
Discover the next generation of hybrid analysis—advancing what’s possible in automated cell imaging and detection.
Visit Booth #4527 at AACR and be one of the first to learn more.
Exhibitor Spotlight Session
Direct Targeted Methylation Sequencing (dTMS) with SureSelect: targeted long-read sequencing for native variant and methylation profiling in oncology
Presented by: Andrew Jenkins, Biotechnology Research Associate, Wasatch Biolabs
Date: Monday, April 20, 2026
Time: 10:00 AM - 11:00 AM PST
Location: Theater D
xCELLigence Cancer & Immunotherapy Symposium
Learn more about the work being done by the incredible speakers listed below:
Super‑charged NK cells increase immune infiltration in the tumor microenvironment and inhibit tumor growth
Presented by: Dr. Kawaljit Kaur, CEO, ImmuneLink; Scientific Advisor on NK cells and/or cell‑based immunotherapies; Biotech Investor
The impact of microbial-derived metabolites on innate immune cell anti‑cancer activities
Presented by: Dr. Katherine Cook, Associate Professor, Wake Forest University
Strategies to overcome breast-to-brain metastasis
Presented by: Dr. David Soto-Pantoja, Associate Professor / Principal Investigator, Wake Forest University
Event Details:
Date: Saturday April 18, 2025
Time: 1:00 PM - 6:00 PM
Location: University of California San Diego Campus
Theatre District – Survivance 1126 conference room 11th floor of the Survivance Building
Poster Presentations
-
-
Artificial intelligence-based spatial analysis of the local tumor micro environment in relation to c-MET expression in non-small cell lung cancer.
Date: | Time: Coming soon...
Section no. | Poster no. | Abstract no. -
Integrated long-read target enrichment and comprehensive genomic profiling for hematologic malignancies using the SureSelect Cancer Pan Heme Assay
Date: Monday, April 20 | Time: 2:00 PM - 5:00 PM
Section no. 22 | Poster no. 7 | Abstract no. 3242 -
Where sensitivity meets complexity: electrophoretic assessment of genomic DNA integrity at low concentrations and for FFPE samples using DIN-based analysis
Date: Monday, April 20 | Time: 2:00 PM - 5:00 PM
Section no. 22 | Poster no. 28 | Abstract no. 3263 -
Real-time imaging for quantitative assessment of antibody-drug conjugate internalization
Date: Monday, April 20 | Time: 9:00 AM - 12:00 PM
Section no. 11 | Poster no. 7 | Abstract no. 1648 -
High-throughput imaging approaches to characterize CAR T therapies for solid tumor microenvironments
Date: Monday, April 20 | Time: 9:00 AM - 12:00 PM
Section no. 28 | Poster no. 2 | Abstract no. 2130 -
Integrated real-time impedance and fluorescence imaging to characterize NETosis
Date: Tuesday, April 21 | Time: 9:00 AM - 12:00 PM
Section no. 20 | Poster no. 24 | Abstract no. 4675 -
Detection of mitochondria-targeting anticancer agents in tumor organoids
Date: Tuesday, April 21 | Time: 9:00 AM - 12:00 PM
Section no. 122 | Poster no. 13 | Abstract no. 4715 -
A fully automated walkaway system programmed with a novel library prep target enrichment protocol for detection of ultra-low frequency mutations in liquid biopsy and tumor samples
Date: Wednesday, April 22 | Time: 9:00 AM - 12:00 PM
Section no. 21 | Poster no. 2 | Abstract no. 7262
-
Ask a Question
To request more information about the press conference content or learn more about Agilent's cancer research solutions contact:
Agilent Public Relations
pdl-business-pr@agilent.com